Skip to main content
. Author manuscript; available in PMC: 2011 Feb 18.
Published in final edited form as: Ann Allergy Asthma Immunol. 2010 Jan;104(1):30–35. doi: 10.1016/j.anai.2009.11.004

Figure 1.

Figure 1

Asthma controller medication use reported in the Childhood Asthma Management Program posttrial observation period. The bars represent the percentage of participants (N = 914) who reported using any of 3 classes of asthma controller medication, either alone or in any combination during at least 1 of the 4 encounters during each follow-up year. ICS indicates inhaled corticosteroid; LABA, long-acting β-agonist; LTRA, leukotriene receptor antagonist.